Uterine Fibroids Diagnosis
Uterine Fibroids Diagnosis
The assessment is built from the symptoms, the examination and imaging together, and what imaging is asked to answer is not simply whether fibroids are present but where each one sits. That is the finding that predicts the bleeding and the pressure, and it is also the finding that decides which operations are technically possible. Ultrasound shows the number, size and position and at the same time the lining of the womb and the ovaries. Where a fibroid lies near the cavity, the cavity itself is looked at directly, because how far it projects inwards decides whether heavy bleeding can be treated through the cervix. MRI is used where the womb is very large, where the fibroids are numerous, or where an operation is being planned.
There is no blood test, and the blood count is not one
The absence of a simple test is the reason the history and the examination carry so much of the assessment:
- No blood test identifies fibroids. There is no marker that rises with them, and none that tracks what they are doing, so nothing in the blood can be followed to see whether they are changing.
- The blood count is done to measure anaemia, not to find the fibroids. It is a genuinely important test, because years of heavy bleeding can produce anaemia that needs correcting in its own right, and it is sometimes the finding that starts the whole assessment. It is not evidence about the fibroids themselves.
- A tumour marker is not a fibroid test. Markers used elsewhere are not diagnostic here, and treating a mildly raised result as though it measured the fibroids leads to decisions based on nothing, including operations that were not needed.
- The examination is part of the assessment, not a formality. The size, shape, mobility and tenderness of the womb are felt directly, and those findings change both what is suspected and what can be planned.
Why the absence of a test is worth explaining. Patients reasonably expect a blood test that settles the question, and when there is not one, the gap gets filled by tests that cannot answer it. Saying plainly what the assessment is built from is what keeps it about the decisions.
What transvaginal ultrasound can and cannot show
Ultrasound is the first-line test, and it is read for position as much as for size:
- The number, size and position of the fibroids. Whether each one lies within the wall, bulges towards the cavity or grows outwards is the finding that decides what it is likely to be causing.
- The size and shape of the womb, and the lining. The lining is measured and examined for polyps, which cause heavy bleeding in the same way and are treated differently.
- The ovaries and the muscle of the womb. The ovaries are looked at because a pelvic mass is not always a fibroid, and the muscle is read for the changes of adenomyosis, which commonly occurs alongside fibroids and answers to different treatment.
- Its limits. How far a fibroid projects into the cavity is difficult to judge from the outside, particularly where several are present, and a womb that is very large or has many fibroids is harder to map completely. Both limits have a specific answer: looking at the cavity directly, or MRI.
Why the position rather than the number is the part that matters. A report listing three fibroids and their measurements has not yet answered the question that decides treatment: whether any of them is distorting the cavity.
Where the cavity has to be looked at directly
When a fibroid lies near the cavity, the cavity itself becomes the thing that needs to be seen:
- Saline infusion sonography. A small amount of fluid is placed in the cavity and the ultrasound is repeated, which separates the lining from anything projecting into it and shows how far a fibroid pushes in. It is done in an outpatient setting and it answers a specific question.
- Hysteroscopy. A camera is passed through the cervix to look at the cavity from the inside. It shows the shape and the extent of a fibroid projecting into the cavity, and where it is suitable it is also the route by which that fibroid can be removed.
- Why this matters more than anything else for heavy bleeding. A fibroid that can be reached through the cervix can be treated without an abdominal incision, so establishing whether it projects into the cavity decides which operation is offered rather than how large the fibroid is.
Why one look at the cavity is worth several scans. A fibroid that distorts the cavity is the type most likely to cause bleeding and to affect conception, and it is the type whose treatment differs most from the others. Where heavy bleeding is the main problem, the cavity is examined rather than inferred.
What MRI adds, and when it is worth doing
MRI is not needed for everyone, and it is worth being clear about what it is for:
- Where the fibroids are numerous or the womb is very large. When several are present, MRI maps each one and its relationship to the cavity and the outer surface more reliably than ultrasound, which is what an operation has to be planned around.
- Where adenomyosis may also be present. Telling fibroids from adenomyosis changes the treatment, because a fibroid can be removed while the womb is kept and adenomyosis cannot. MRI is better at showing the difference.
- Before an operation or a procedure. It shows the position and the blood supply of each fibroid, which is what decides whether a womb-preserving operation is technically possible and how much of the womb would remain.
Why not everyone needs one. An MRI adds cost, time and a finding that may not change anything. Where a single fibroid is projecting into the cavity and the plan is already clear, it answers nothing further. It is offered where the answer would change what is done.
What the report needs to say, and why
The useful report describes position, and the patient is entitled to ask for it:
- The position of each fibroid in relation to the cavity and the outer surface. Whether it is within the wall, pushing inwards or growing outwards is what predicts the symptoms and what decides which operations are possible.
- The size of the womb as a whole, and the largest dimension of each fibroid. Recorded so that a later examination can be compared with it, rather than reported once as a single number.
- The lining of the womb and the ovaries. Because bleeding has several causes and a pelvic mass is not always a fibroid.
- Whether the muscle shows the changes of adenomyosis. Because the two conditions often occur together and the plan has to say which one is being treated.
Why it is reasonable to ask. A report that names the size of the largest fibroid and stops there does not answer the question the treatment depends on. Asking where each one sits is not a technical request, it is the question that decides what happens next.
What is not done, and why
A useful assessment is defined as much by what it leaves out as by what it includes:
- Repeated ultrasound to watch fibroids that are causing nothing. Imaging does not guide the treatment of fibroids that are producing no symptoms, and repeating it at intervals turns a decision into a habit. A review point is set, and what is watched is the symptoms.
- Serial blood markers. There is no marker to follow, and treating a non-specific result as a measure of what the fibroids are doing leads to decisions that have nothing behind them.
- Taking a sample from the fibroid to confirm it is a fibroid. The appearance on imaging is characteristic, a biopsy carries risks of its own, and the result would not change what is offered — which is the test every investigation has to pass.
- Operating to find out what is happening. An operation is for treatment: reducing bleeding, relieving pressure, removing the fibroids while keeping the womb, or removing the womb when that is the agreed plan. It is not the way the diagnosis is reached.
Why saying no is part of the plan. Someone who has bled heavily for years will accept almost any test that is offered, and a test that cannot answer the question only postpones the treatment that can. Naming what will not be done is how the assessment stays about decisions.